EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) FOR PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN COVID-19
Date of publication: September 10, 2020
Objectives:
- To search and synthesize information on the use of Extracorporeal Machine Oxygenation (ECMO) in Acute Respiratory Distress Syndrome in COVID-19 in different countries
- To search for existing position/recommendation of HTA agencies on ECMO for COVID-19
- To search and synthesize information on existing evidence on the performance of ECMO in ARDS in terms of the following outcomes:
-
- Survival rate
- Hospitalization days
- Resolution of symptoms
- Incidence of adverse events
-
- To search and synthesize information on the technical, infrastructural, logistical, and organizational need in implementing ECMO for COVID-19 patients with ARDS.
Evidence summary:
Rapid review:
Decision of the Secretary of Health: